International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 5 , Pages 1537-1546 , 1 August 2008

Underestimation of Low-Dose Radiation in Treatment Planning of Intensity-Modulated Radiotherapy

  • Si Young Jang, Ph.D.
    • ,
  • H. Helen Liu, Ph.D.

      Affiliations

    • Corresponding Author InformationReprint requests to: H. Helen Liu, Ph.D., Department of Radiation Physics, Unit 94, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Tel: (713) 563-2546; Fax: (713) 563-2545
    • ,
  • Radhe Mohan, Ph.D.

Received 22 September 2007 ,Revised 26 March 2008 ,Accepted 7 April 2008.

References 

  1. Murshed H, Liu HH, Liao Z, et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;58:1258–1267
  2. Chandra A, Guerrero TM, Liu HH, et al. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol. 2005;77:247–253
  3. Zhu XR, Prado K, Liu HH, et al. Intensity-modulated radiation therapy for mesothelioma: Impact of multileaf collimator leaf width and pencil beam size on planning quality and delivery efficiency. Int J Radiat Oncol Biol Phys. 2005;62:1525–1534
  4. Jang SY, Liu HH, Wang X, et al. Dosimetric verification for intensity-modulated radiation therapy of thoracic cancers using experimental and Monte Carlo approaches. Int J Radiat Oncol Biol Phys. 2006;66:939–948
  5. Kim JO, Siebers JV, Keall PJ, et al. A Monte Carlo study of radiation transport through multileaf collimators. Med Phys. 2001;28:2497–2506
  6. Yorke ED, Jackson A, Rosenzweig KE, et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:672–682
  7. Wang SL, Liao Z, Vaporciyan AA, et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys. 2006;64:692–699
  8. Allen AM, Czerminska M, Janne PA, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys. 2006;65:640–645
  9. Jang SY, Liu HH, Mohan R, et al. Variations in energy spectra and water-to-material stopping-power ratios in three-dimensional conformal and intensity-modulated photon fields. Med Phys. 2007;34:1388–1397
  10. Palm A, Kirov AS, LoSasso T. Predicting energy response of radiographic film in a 6 MV x-ray beam using Monte Carlo calculated fluence spectra and absorbed dose. Med Phys. 2004;31:3168–3178
  11. Boudreau C, Heath E, Seuntjens J, et al. IMRT head and neck treatment planning with a commercially available Monte Carlo based planning system. Phys Med Biol. 2005;50:879–890
  12. Ma CM, Pawlicki T, Jiang SB, et al. Monte Carlo verification of IMRT dose distributions from a commercial treatment planning optimization system. Phys Med Biol. 2000;45:2483–2495
  13. Yang J, Li J, Chen L, et al. Dosimetric verification of IMRT treatment planning using Monte Carlo simulations for prostate cancer. Phys Med Biol. 2005;50:869–878
  14. Rice DC, Smythe WR, Liao Z, et al. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2007;69:350–357
  15. Jang SY, Vassiliev ON, Liu HH, et al. Development and commissioning of a multi-leaf collimator model for intensity-modulated radiation therapy. Med Phys. 2006;33:770–781
  16. Rogers DWO, Ma C, Ding GX, et al. BEAMnrc users manual. National Research Council Report PIRS-0509(A) revision G. Ottawa, Ontario, Canada: National Research Council; 2002;
  17. Van Dyk J, Barnett RB, Cygler JE, et al. Commissioning and quality assurance of treatment planning computers. Int J Radiat Oncol Biol Phys. 1993;26:261–273
  18. Fraass B, Doppke K, Hunt M, et al. American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning. Med Phys. 1998;25:1773–1829
  19. Yom SS, Liao Z, Liu HH, et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:94–102
  20. Komaki R, Liao Z, Liu H, et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma: In regard to Allen, et al. (Int J Radiat Oncol Biol Phys 2006;65:640-645) Int J Radiat Oncol Biol Phys. 2006;66:1595–1596author reply 1596
  21. Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2006;66:1399–1407

 Supported in part by National Cancer Institute grant R01-CA074043-08A2.

 Presented at the 49th Annual Meeting of the American Association of Physicists in Medicine, July 22–26, 2007, Minneapolis, MN.

 Conflict of interest: none.

PII: S0360-3016(08)00656-1

doi: 10.1016/j.ijrobp.2008.04.014

International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 5 , Pages 1537-1546 , 1 August 2008

Article Tools

* Image Usage & Resolution